Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts


  Free Subscription


2 Antimicrob Agents Chemother
1 Clin Exp Immunol
1 Eur Respir J
1 J Antimicrob Chemother
1 J Clin Microbiol
1 J Infect
8 PLoS One
2 Trop Med Int Health

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Antimicrob Agents Chemother

  1. KEMPKER RR, Heinrichs MT, Nikolaishvili K, Sabulua I, et al
    Lung Tissue Concentrations of Pyrazinamide among Patients with Drug-Resistant Pulmonary Tuberculosis.
    Antimicrob Agents Chemother. 2017 Apr 3. pii: AAC.00226.
    PubMed     Text format     Abstract available

  2. CHEN X, Hashizume H, Tomishige T, Nakamura I, et al
    Delamanid Kills Dormant Mycobacteria in Vitro and in the Guinea Pig Model of Tuberculosis.
    Antimicrob Agents Chemother. 2017 Apr 3. pii: AAC.02402.
    PubMed     Text format     Abstract available

    Clin Exp Immunol

  3. ABEBE F, Belay M, Legesse M, Mihret A, et al
    Association of ESAT-6/CFP-10-induced IFN-gamma, TNF-alpha and IL-10 with clinical tuberculosis: Evidence from cohorts of pulmonary tuberculosis patients, household contacts, and community controls in an endemic setting.
    Clin Exp Immunol. 2017 Apr 3. doi: 10.1111/cei.12972.
    PubMed     Text format     Abstract available

    Eur Respir J

  4. CATANZARO DG, Trollip AP, Seifert M, Georghiou SB, et al
    Evaluation of the microscopic observation drug susceptibility assay for the detection of first- and second-line drug susceptibility for Mycobacterium tuberculosis.
    Eur Respir J. 2017;49.
    PubMed     Text format    

    J Antimicrob Chemother

  5. ZIMENKOV DV, Nosova EY, Kulagina EV, Antonova OV, et al
    Examination of bedaquiline- and linezolid-resistant Mycobacterium tuberculosis isolates from the Moscow region.
    J Antimicrob Chemother. 2017 Apr 6. doi: 10.1093.
    PubMed     Text format     Abstract available

    J Clin Microbiol

  6. SHEA J, Halse TA, Lapierre P, Shudt M, et al
    Comprehensive whole-genome sequencing and reporting of drug resistance profiles on clinical cases of Mycobacterium tuberculosis in New York State.
    J Clin Microbiol. 2017 Apr 5. pii: JCM.00298-17. doi: 10.1128/JCM.00298.
    PubMed     Text format     Abstract available

    J Infect

  7. SIMONSEN DF, Farkas DK, Horsburgh CR, Thomsen PR, et al
    Increased risk of active Tuberculosis after Cancer diagnosis.
    J Infect. 2017 Mar 30. pii: S0163-4453(17)30105.
    PubMed     Text format    

    PLoS One

  8. KHALIQ A, Ravindran R, Hussainy SF, Krishnan VV, et al
    Field evaluation of a blood based test for active tuberculosis in endemic settings.
    PLoS One. 2017;12:e0173359.
    PubMed     Text format     Abstract available

  9. UREN C, Henn BM, Franke A, Wittig M, et al
    A post-GWAS analysis of predicted regulatory variants and tuberculosis susceptibility.
    PLoS One. 2017;12:e0174738.
    PubMed     Text format     Abstract available

  10. KE CC, Lin CS, Yeh CC, Chung CL, et al
    Correction: Adverse Outcomes after Non-Chest Surgeries in Patients with Pulmonary Tuberculosis: A Nationwide Study.
    PLoS One. 2017;12:e0175603.
    PubMed     Text format     Abstract available

  11. ALMEIDA FM, Ventura TL, Amaral EP, Ribeiro SC, et al
    Correction: Hypervirulent Mycobacterium tuberculosis strain triggers necrotic lung pathology associated with enhanced recruitment of neutrophils in resistant C57BL/6 mice.
    PLoS One. 2017;12:e0175652.
    PubMed     Text format     Abstract available

  12. ZHANG H, Xin H, Li X, Li H, et al
    A dose-response relationship of smoking with tuberculosis infection: A cross-sectional study among 21008 rural residents in China.
    PLoS One. 2017;12:e0175183.
    PubMed     Text format     Abstract available

  13. MIRANDA P, Gil-Santana L, Oliveira MG, Mesquita ED, et al
    Sustained elevated levels of C-reactive protein and ferritin in pulmonary tuberculosis patients remaining culture positive upon treatment initiation.
    PLoS One. 2017;12:e0175278.
    PubMed     Text format     Abstract available

  14. LOPEZ-VARELA E, Garcia-Basteiro AL, Augusto OJ, Fraile O, et al
    Correction: High Rates of Non-Tuberculous Mycobacteria Isolation in Mozambican Children with Presumptive Tuberculosis.
    PLoS One. 2017;12:e0175613.
    PubMed     Text format     Abstract available

  15. KJAERGAARD J, Stensballe LG, Birk NM, Nissen TN, et al
    Lack of a Negative Effect of BCG-Vaccination on Child Psychomotor Development: Results from the Danish Calmette Study - A Randomised Clinical Trial.
    PLoS One. 2016;11:e0154541.
    PubMed     Text format     Abstract available

    Trop Med Int Health

  16. WIKMAN-JORGENSEN PE, Llenas-Garcia J, Perez-Porcuna TM, Hobbins M, et al
    Microscopic observation drug-susceptibility assay vs Xpert(R) MTB/RIF for the diagnosis of tuberculosis in a rural African setting: a cost-utility analysis.
    Trop Med Int Health. 2017 Apr 5. doi: 10.1111/tmi.12879.
    PubMed     Text format     Abstract available

  17. SHIRLY S, Shanmugam S, Devi KR, Latha PN, et al
    Spoligotyping of Mycobacterium tuberculosis isolates at a tertiary care hospital in India.
    Trop Med Int Health. 2017 Apr 4. doi: 10.1111/tmi.12875.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.